Priyank Shah

Priyank Shah is a seasoned professional in Regulatory Affairs, currently serving as Senior Manager at Intellia Therapeutics, Inc. since November 2022. Prior experience includes managerial roles at Verastem Oncology from September 2019 to November 2022 and Boston Biomedical, Inc. from July 2015 to September 2019, where responsibilities involved regulatory compliance and eCTD submissions for new drug products. Early career experience includes positions as Regulatory Affairs Specialist at Bio-Pharm Inc. and a Research Assistant at the Center for Pharmaceutical Biotechnology & Nanomedicine, focusing on drug formulation and characterization. Priyank also completed internships at Khandelwal Labs Pvt Ltd and Bombay Hospital, gaining insights into quality control and regulatory documentation. Educational qualifications consist of an MS in Regulatory Affairs from Northeastern University and a Bachelor of Pharmacy from Dr. Bhanuben Nanavati College of Pharmacy.